Gordon Stein, CFO of CleanTech Lithium, explains why CTL acquired the 23 Laguna Verde licenses. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPATH.L Regulatory News (PATH)

  • There is currently no data for PATH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Fundraising & Lifting of Suspension Application

12 Jun 2020 07:00

RNS Number : 7308P
Path Investments plc
12 June 2020
 

This announcement contains inside information for the purposes of Article 7 of Regulation (EU) 596/2014. Market soundings, as defined in MAR, were taken in respect of the Fundraising with the result that certain persons became aware of inside information, as permitted by MAR. That inside information is set out in this announcement and has been disclosed as soon as possible in accordance with paragraph 7 of article 17 of MAR. Therefore, those persons that received inside information in a market sounding are no longer in possession of inside information relating to the Company and its securities.

12 June 2020

Path Investments plc

("Path" or the "Company")

Fundraising and Application for Lifting of Suspension

 

 

Path Investments plc (TIDM: PATH), the energy and natural resources investment company, is pleased to announce that it has raised £184,000 by way of an oversubscribed placing of 24,188,760 new ordinary shares of 0.01 pence each ("New Ordinary Shares") at a price of 0.75 pence per New Ordinary Share (the "Placing Price") and the sale of 357,142 ordinary shares of 0.1 pence each held by Path as Treasury Stock at a price of 0.75 pence per share (together the "Fundraising"). Keith, Bayley, Rogers & Co. Limited acted as sole placing agent.

 

It is intended that the proceeds of the Fundraising will be used to fund the exploitation of the commercial benefits of Path's recently announced acquisitions of DT Ultravert and the Kansas Nitrogen Reserves and for general working capital purposes.

The Placing Price represents a price equal to the closing mid-market price of 0.75 pence per ordinary share on 15 December 2017, being the last trading date of the Company's ordinary shares on the London Stock Exchange prior to the announcement of the Fundraising. The New Ordinary Shares will represent 10.99 per cent. of the Company's share capital as enlarged by the Fundraising.

Christopher Theis, Chief Executive of Path, commented:

"The Board is pleased that this oversubscribed Fundraising has been completed successfully. This share issue, together with the proposed 15,000,000 share issue to the vendors at completion of our recently announced acquisition, represents the maximum permissible share issuance during the current 12-month period without the publication of a Prospectus.

"We are very excited by the opportunities presented by our acquisition of DT Ultravert and the Kansas Nitrogen Reserves, and in particular the economic and environmental benefits that may be provided from the use of the technology.

"This is the first step in the relaunch of Path and I look forward to providing further updates in due course."

Application for Lifting of Suspension and Admission of New Ordinary Shares

Completion of the Fundraising is conditional, inter alia, upon admission of the New Ordinary Shares to the standard segment of the Official List of the FCA and to trading on the Main Market of the London Stock Exchange ("Admission").

Application has been made to the London Stock Exchange to lift the current suspension of Path's ordinary shares and for the New Ordinary Shares to be admitted to the standard segment of the Official List and to trading on the Main Market; it is expected that Admission of the New Ordinary Shares will take place and that trading will recommence in the Company's ordinary shares at or around 8:00 a.m. on 23 June 2020.

Annual Report and Accounts

 

Owing to the current COVID-19 outbreak, the Company will be unable to complete and post its annual audited accounts to shareholders for the year to 31 December 2019 by 30 June 2020.

 

The Company will publish its annual audited accounts for the year to 31 December 2019 by 30 September 2020. Path has also applied for and been granted an extension to delay the filing of its audited annual accounts by Companies House until 30 September 2020.

 

Total Voting Rights

Following Admission, the Company will have 220,132,562 ordinary shares in issue, each share carrying the right to one vote. Following completion of the Fundraising the Company will no longer hold any shares in treasury. The above figure of 220,132,562 ordinary shares may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information please contact:

Path Investments plc

C/O IFC

Christopher Theis

 

 

 

IFC Advisory (Financial PR & IR)

020 3934 6630

Tim Metcalfe

 

Zach Cohen

 

 

Keith, Bayley, Rogers & Co. Limited (Broker)

 

Brinsley Holman

07776 30 22 28

Graham Atthill-Beck

07506 43 41 07

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
IOEMZGMVVMGGGZM
Date   Source Headline
7th Apr 20227:00 amRNSUpdate on Acquisition
5th Apr 20227:00 amRNSInvestor Presentation
1st Apr 20222:45 pmRNSResult of General Meeting
14th Mar 20221:09 pmRNSPublication of Prospectus, Notice of GM, Fundraise
1st Feb 20227:00 amRNSProposed Transaction Update
31st Dec 20217:00 amRNSProposed Transaction Update
18th Nov 20217:00 amRNSAppointment of Joint Broker
26th Oct 20217:00 amRNSProposed Transaction Update
13th Oct 20216:02 pmRNSCorrection: Holding(s) in Company
13th Oct 20214:52 pmRNSHolding(s) in Company
11th Oct 20217:00 amRNSBlock listing Interim Review
29th Sep 20217:00 amRNSInterim Results for the six months to 30 June 2021
28th Sep 20212:45 pmRNSResult of AGM
22nd Sep 20212:41 pmRNSFurther secured loan provided to DG Innovate
9th Sep 20216:01 pmRNSHolding(s) in Company
2nd Sep 20217:00 amRNSNotice of AGM
18th Aug 202111:54 amRNSCorrection: Holding(s) in Company
18th Aug 20217:00 amRNSHolding(s) in Company
13th Aug 20217:45 amRNSProposed Acquisition of DG Innovate & Suspension
14th Jul 20215:23 pmRNSHolding(s) in Company
14th Jul 20212:39 pmRNSHolding(s) in Company
24th Jun 20217:00 amRNSFinal Results for the Year Ended 31 December 2020
16th Jun 20217:00 amRNSHolding(s) in Company
8th Jun 202111:49 amRNSHolding(s) in Company
7th Jun 202112:04 pmRNSHolding(s) in Company
9th Apr 202110:03 amRNSHolding(s) in Company
9th Apr 20217:00 amRNSBlock Listing
1st Apr 20215:02 pmRNSHolding(s) in Company
31st Mar 20219:55 amRNSTotal Voting Rights
24th Mar 20212:06 pmRNSDirector/PDMR Share Transaction
19th Mar 20218:53 amRNSHolding(s) in Company
12th Mar 20215:36 pmRNSAdmission of previously issued shares
12th Mar 202112:50 pmRNSPublication of Prospectus
8th Mar 202111:05 amRNSSecond Price Monitoring Extn
8th Mar 202111:00 amRNSPrice Monitoring Extension
1st Mar 20214:41 pmRNSSecond Price Monitoring Extn
1st Mar 20214:36 pmRNSPrice Monitoring Extension
26th Feb 20212:06 pmRNSSecond Price Monitoring Extn
26th Feb 20212:00 pmRNSPrice Monitoring Extension
26th Feb 20217:00 amRNSEquity Fundraise Update
19th Feb 20217:00 amRNS£3.5 million Equity Fundraise
15th Feb 20212:00 pmRNSTermination of DTU Acquisition
3rd Dec 20209:44 amRNSSubscription for £55,000 of Convertible Loan Stock
5th Nov 20207:00 amRNSFurther re the Acquisition of 75% of DT Ultravert
8th Oct 20209:55 amRNSOption Surrender and Issue of Replacement Options
5th Oct 20207:00 amRNSProposed sale of Kansas Land Leases and equipment
1st Oct 202011:41 amRNSFurther re the Acquisition of DT Ultravert
30th Sep 20207:00 amRNSBoard Changes & Acquisition of Deferred Shares
10th Sep 20201:30 pmRNSInterim Results for the six months to 30 June 2020
10th Sep 20201:15 pmRNSFinal Results for the Year Ended 31 December 2019

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.